Furthermore, our prior research revealed that targeting MARCKS activity in IPF lung fibroblasts with elevated α-SMA expression led to a reduction in COL1A1 and FN1 expression, AKT activity, and PIP3 levels [26]. The gene discussed is COL1A1; the disease is idiopathic pulmonary fibrosis.